Page 202 - Read Online
P. 202
Nikiforov et al. Proinflammatory monocyte polarization in T2DM and CHD
of chronic inflammation. Unexpectedly, we found Nedosugova LV, Kaminnyi AI, Tikhaze AK, Ageev FT, Kukharchuk
diametrically different abilities of monocytes from T2DM VV, Belenkov YN. Oxidative stress in atherosclerosis and diabetes.
and CHD to respond under pro-inflammatory stimulus. Bull Exp Biol Med 2005;140:41-3.
7. Lavi S, McConnell JP, Rihal CS, Prasad A, Mathew V, Lerman LO,
Lerman A. Local production of lipoprotein-associated phospholipase
DECLARATIONS A2 and lysophosphatidylcholine in the coronary circulation: association
with early coronary atherosclerosis and endothelial dysfunction in
humans. Circulation 2007;115:2715-21.
Authors’ contributions 8. Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA.
Concept and performed experimental studies, general Inflammatory and thrombotic mechanisms in coronary atherosclerosis.
coordination, supervision of the research projectand Heart 2003;89:993-7.
wrote the manuscript: N.G. Nikiforov 9. Bonizzi G, Karin M. The two NF-kappaB activation pathways
Literature search and patients’ recruitment: L.V. and their role in innate and adaptive immunity. Trends Immunol
Nedosugova 2004;25:280-8.
Clinical examination and clinical data acquisition: K.O. 10. Lawrence T, Gilroy DW. Chronic inflammation: a failure of resolution?
Int J Exp Pathol 2007;88:85-94.
Galstyan 11. MantovaniA,Sozzani S, Locati M, Allavena P, Sica A. Macrophage
Cell culture experiments: N.V. Elizova, K.I. Kolmychkova polarization: tumor-associated macrophages as a paradigm for
Manuscript editing: E.A. Ivanova polarized M2 mononuclear phagocytes. Trends Immunol 2002;2:549-
55.
Financial support and sponsorship 12. Arzamastseva NE, Lankin VZ, Konovalova GG, Tikhaze AK, Ageev
This work was supported by Russian Science FT, Lapina YV, Narusov OY, Mareev VY, Belenkov YN. Oxidative
stress in patients with chronic heart failure and type 2 diabetes mellitus.
Foundation (Grant # 14-15-00112). Bull ExpBiol Med 2007;143:207-9.
13. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin
Conflicts of interest Invest 2005;115:1111-9.
There are no conflicts of interest. 14. Neels JG, Olefsky JM. Inflamed fat: what starts the fire? J Clin Invest
2006;116:33-5.
Patient consent 15. Sobenin IA, Galitsyna EV, Grechko AV, Orekhov AN. Small dense and
All participants gave their written informed consent desialylated low density lipoprotein in diabetic patients. Vessel Plus
2017;1:29-37.
prior to their inclusion in the study. 16. Fernandez-Real JM, Ricart W. Insulin resistance and chronic
cardiovascular inflammatory syndrome. Endocr Rev 2003;24:278-301.
Ethics approval 17. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL.
It was approved by the local ethics committee of Characterisation of the mechanism for the chronic activation of
the Institute for Atherosclerosis Research, Skolkovo diacylglycerol-protein kinase C in diabetes and hypergalactosaemia.
Innovation Center, Moscow, Russia. Diabetes 1994;43:1122-9.
18. Ceolotto G, Gallo A, Miola M, Sartori M, Trevisan R, Del Prato S,
Semplicini A, Avogaro A. Protein kinase C activity is acutely regulated
REFERENCES by plasma glucose concentration in human monocytes in vivo.
Diabetes 1999;48:1316-22.
1. IDF Diabetes Atlas 7th Edition (2015). Available from: 19. Jin X, Yao T, Zhou Z, Zhu J, Zhang S, Hu W, Shen C. Advanced
http://www.idf.org/e-library/epidemiology-research/diabetes-atlas.html. glycation end products enhance macrophages polarization into M1
[Last accessed on 29 Sep 2017] phenotype through activating RAGE/NF-kB pathway. Bio Med Res Int
2. Kanter JE, Bornfeldt KE. Inflammation and diabetes-accelerated 2015;2015:732450.
atherosclerosis: myeloid cell mediators. Trends Endocrinol Metab 20. Bouhlel MA, Derudas B, Rigamonti E, Dièvart R, Brozek J, Haulon S,
2013;24:137-44. Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi
3. Coutinho M, Gerstein HC,Wang Y, Yusuf S. The relationship between G. PPARgamma activation primes human monocytes into alternative
glucose and incident of cardiovascular events. A meta regression M2 macrophages with anti-inflammatory properties. Cell Metab
analysis of published data from 20 studies of 93,7883 individuals 2007;6:137-43.
followed for 12.5 years. Diabetes Care 1999;22:233-40. 21. Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun HL.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic Macrophage polarization in obesity and type 2 diabetes: weighing
complications. Nature 2001;414:813-20. down our understanding of macrophage function? Front Immunol
5. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress 2014;470:1-6.
and stress-activated signaling pathways: a unifying hypothesis of type 22. Ivanova EA, Orekhov AN. Monocyte activation in immunopathology:
2 diabetes. Endocr Rev 2002;23:599-622. cellular test for development of diagnostics and therapy. J Immunol
6. Lankin VZ, Lisina MO, Arzamastseva NE, Konovalova GG, Res 2016;2016:4789279.
Vessel Plus ¦ Volume 1 ¦ December 28, 2017 195